The Bausch + Lomb Trulign toric accommodating posterior chamber ocular lens has received premarket approval from the Ophthalmic Devices Panel of the FDA, according to a Medscape report.
On April 8, 10 of the 12 panel members voted that the intraocular lens was safe, effective and had benefits that outweighed its risks.
More Articles on Ophthalmology:
Researchers Find Possible Prevention of Retinal Detachment Side Effect
FDA Approves PROLENSA from Bausch + Lomb
Bausch + Lomb VICTUS Femtosecond Laser Earns CE Mark
On April 8, 10 of the 12 panel members voted that the intraocular lens was safe, effective and had benefits that outweighed its risks.
More Articles on Ophthalmology:
Researchers Find Possible Prevention of Retinal Detachment Side Effect
FDA Approves PROLENSA from Bausch + Lomb
Bausch + Lomb VICTUS Femtosecond Laser Earns CE Mark